"10.1371_journal.pone.0118947","plos one","2015-04-01T00:00:00Z","Marta Garcia-Miralles; Janaky Coomaraswamy; Karina HÃ¤big; Martin C Herzig; Natalja Funk; Frank Gillardon; Martina Maisel; Mathias Jucker; Thomas Gasser; Dagmar Galter; Saskia Biskup","Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and DZNE, German Center for Neurodegenerative Diseases, 72076 Tuebingen, Germany; Department of Cellular Neurology, Hertie-Institute for Clinical Brain Research and DZNE, German Center for Neurodegenerative Diseases, 72076 Tuebingen, Germany; Department of Medical Genetics and Applied Genomics, Institute of Human Genetics, University of Tuebingen, 72076 Tuebingen, Germany; Boehringer Ingelheim Pharma GmbH & Co. KG, CNS Research, 88397 Biberach an der Riss, Germany; Department of Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden","Conceived and designed the experiments: MGM JC KH MHC NF FG MM MJ TG DG SB. Performed the experiments: MGM JC DG NF. Generated transgenic mice: JC MHC MJ. Analyzed the data: MGM DG. Contributed reagents/materials/analysis tools: NF FG MM. Wrote the paper: MGM DG SB.","The authors have the following interests. F. Gillardon is employed by Boehringer Ingelheim Pharma GmbH & Co, J. Coomaraswamy is employed by Biogen Idec Inc., and M.C. Herzig was a former employee of Novartis Pharma AG and H. Lundbeck A/S. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2015","04","Marta Garcia-Miralles","MGM",11,TRUE,11,4,2,3,TRUE,TRUE,TRUE,1,"4",FALSE
